Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

12.09
-0.4300-3.43%
Pre-market: 12.100.0076+0.06%05:54 EDT
Volume:2.21M
Turnover:26.93M
Market Cap:1.07B
PE:-3.59
High:12.61
Open:12.50
Low:11.99
Close:12.52
52wk High:13.90
52wk Low:7.36
Shares:88.77M
Float Shares:70.60M
Volume Ratio:1.44
T/O Rate:3.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3668
EPS(LYR):-3.1784
ROE:-167.71%
ROA:-31.30%
PB:22.16
PE(LYR):-3.80

Loading ...

Kura Oncology CEO Troy Wilson Reports Purchase of 100,000 Common Shares Worth $1.11 Million

Reuters
·
Aug 18

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

Kura Jumps on Narrower-than-Expected Quarterly Loss

Reuters
·
Aug 13

Phil Nadeau Reiterates Buy on Kura Oncology as Komzifti Outperforms Expectations and Pipeline Progress Strengthens Long-Term Outlook

TIPRANKS
·
Aug 13

Kura Oncology Price Target Raised to $38.00/Share from $36.00 by Wedbush

Dow Jones
·
Aug 13

Karyopharm Q2 Revenue Falls as License Revenue Drops; Expects Funds to Last into September

Reuters
·
Aug 13

Wedbush Adjusts Price Target on Kura Oncology to $38 From $36, Keeps Outperform Rating

MT Newswires Live
·
Aug 13

Barclays Reaffirms Their Buy Rating on Kura Oncology (KURA)

TIPRANKS
·
Aug 13

Sweden's RaySearch Q2 Order Intake Rises on Clinical Adoption

Reuters
·
Aug 13

Kura Oncology, Inc. : Leerink Partners Raises Target Price to $28 from $21

THOMSON REUTERS
·
Aug 13

Kura Oncology Posts Corporate Presentation on Komzifti Launch, Ziftomenib Pipeline Strategy

Reuters
·
Aug 13

Kura Oncology, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Earnings Flash (KURA) Kura Oncology Posts Q2 Loss Per Share $0.77, vs. FactSet Est of Loss $0.88

MT Newswires Live
·
Aug 13

Kura Oncology Q2 Product Revenue Rises 57% on Komzifti Uptake

Reuters
·
Aug 13

Kura Oncology 2Q FY26 Net Loss Widens to $68.3 Million; Revenue Rises to $20.87 Million

Reuters
·
Aug 13

Kura Oncology Q2 EPS $(0.77) Beats $(0.87) Estimate, Sales $20.874M Miss $21.420M Estimate

Benzinga Earnings
·
Aug 13

Kura Oncology Q2 Operating Expenses USD 93.884 Million

Reuters
·
Aug 13

Kura Oncology Q2 Net Income USD -68.327 Million

THOMSON REUTERS
·
Aug 13

Kura Oncology, Inc. Expected to Post a Loss of 88 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Kura Oncology Highlights Ziftomenib Preclinical Activity, Menin Binding Profile in Blood Publication

Reuters
·
Aug 10